EWM
SIOX

Edge Wealth Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Edge Wealth Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-320
Closed -$1K – 492
2021
Q4 		$1K Hold
320
– – ﹤0.01% 509
2021
Q3 		$1K Hold
320
– – ﹤0.01% 524
2021
Q2 		$1K Hold
320
– – ﹤0.01% 429
2021
Q1 		$1K Hold
320
– – ﹤0.01% 423
2020
Q4 		$1K Hold
320
– – ﹤0.01% 373
2020
Q3 		$1K Hold
320
– – ﹤0.01% 426
2020
Q2 		$1K Buy
320
+292
+1,043% +$937 ﹤0.01% 658
2020
Q1 		$1K Sell
28
-26,752
-100% -$96.6K ﹤0.01% 614
2019
Q4 		$1.44M Buy
26,780
+26,752
+95,543% +$148K 0.29% 58
2019
Q3 		$1K Hold
28
– – ﹤0.01% 581
2019
Q2 		$1K Sell
28
-1
-3% -$8 ﹤0.01% 585
2019
Q1 		$0 Hold
29
– – ﹤0.01% 621
2018
Q4 		$0 Hold
29
– – ﹤0.01% 639
2018
Q3 		$1K Hold
29
– – ﹤0.01% 594
2018
Q2 		$1K Hold
29
– – ﹤0.01% 564
2018
Q1 		$1K Hold
29
– – ﹤0.01% 540
2017
Q4 		$1K Sell
29
-175
-86% -$7.85K ﹤0.01% 521
2017
Q3 		$11K Buy
+204
New +$34.4K ﹤0.01% 359

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Edge Wealth Management's SIOX Position: Q1 2022 in Review

Edge Wealth Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2022, closing a stake of 320 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in SIOX in Q3 2017 and held it in 18 quarters. The position peaked at $1.44M in Q4 2019. 41 funds tracked by Wall St. Rank hold SIOX as of Q1 2022.

  • Edge Wealth Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Edge Wealth Management sold 320 Sio Gene Therapies Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • Edge Wealth Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2017 and held it in 18 quarters.
  • Edge Wealth Management's Sio Gene Therapies Inc. Common Stock position peaked at $1.44M in Q4 2019.
  • 41 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.